Pfizer Inc. (PFE)
25.33
-0.44
(-1.71%)
USD |
NYSE |
Dec 09, 16:00
25.35
+0.02
(+0.08%)
After-Hours: 20:00
Pfizer EPS Diluted (Quarterly): 0.6197 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Viking Therapeutics, Inc. | -0.8083 |
| Arvinas, Inc. | -0.4795 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.55B |
| Revenue (Quarterly) | 16.65B |
| Total Expenses (Quarterly) | 13.11B |
| Enterprise Value | 191.04B |
| Gross Profit Margin (Quarterly) | 67.15% |
| Profit Margin (Quarterly) | 21.32% |
| Earnings Yield | 6.77% |
| Operating Earnings Yield | 13.45% |
| Normalized Earnings Yield | 10.46 |